Episodes from Cuimc

Revolutionary Universal Antiviral Therapy Explained

In this episode, we explore groundbreaking research from Columbia University, where Dr. Dusan Bogunovic reveals how a rare genetic mutation is inspiring a revolutionary universal antiviral therapy. This therapy aims to replicate the immune resilience observed in a small group of individuals resistant to various viral infections. Dr. Bogunovic discusses the role of the ISG15 protein and how the induced chronic inflammation enhances the body’s ability to fight viruses. Promising results from recent studies on hamsters and mice suggest that this therapy could offer broad-spectrum protection against multiple viruses, including influenza and SARS-CoV-2. Tune in to discover the potential implications for public health and what the future holds for this groundbreaking research!